Project

Development and validation of an oral influenza A vaccine based on M2e-expressing bacteriophages

Code
3F016907
Duration
01 October 2007 → 11 January 2010
Funding
Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
Research disciplines
  • Medical and health sciences
    • Vaccinology
Keywords
influenza M2e mucosal vaccins
 
Project description

The aim is to generate an orally administrable influenza A vaccine based on the conserved ectodomain of M2 (M2e) and for veterniary purposes. The filamentous fc phage will be used as a carrier. The vaccine will be targeted to M cells in the gut by using a bioadhesine.